VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $335,266 | -2.9% | 50,875 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $345,441 | -8.1% | 50,875 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $375,966 | -28.4% | 50,875 | -4.2% | 0.00% | -25.0% |
| Q3 2022 | $525,000 | -57.0% | 53,110 | -50.8% | 0.00% | -42.9% |
| Q1 2022 | $1,221,000 | -27.9% | 107,985 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $1,694,000 | -8.5% | 107,985 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $1,851,000 | -20.3% | 107,985 | 0.0% | 0.02% | -15.8% |
| Q2 2021 | $2,323,000 | +43.2% | 107,985 | 0.0% | 0.02% | +35.7% |
| Q1 2021 | $1,622,000 | +101.5% | 107,985 | +76.2% | 0.01% | +100.0% |
| Q4 2020 | $805,000 | +160.5% | 61,300 | +91.6% | 0.01% | +133.3% |
| Q3 2020 | $309,000 | -53.3% | 32,000 | -20.6% | 0.00% | -50.0% |
| Q4 2019 | $661,000 | -29.8% | 40,300 | -43.2% | 0.01% | -33.3% |
| Q3 2019 | $942,000 | – | 70,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |